- Home
- NUWE vs TNON Comparison
NUWE vs TNON Comparison
Compare NUWE & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NUWE | TNON |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2M | 3.3M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NUWE | TNON |
|---|---|---|
| Price | $0.76 | $4.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.7M | ★ 2.1M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.90 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,270,000.00 | $3,944,000.00 |
| Revenue This Year | $11.14 | $65.95 |
| Revenue Next Year | $18.51 | $50.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.35 |
| 52 Week Low | $0.08 | $0.13 |
| 52 Week High | $6.40 | $17.84 |
Technical Indicators
Market Signals| Indicator | NUWE | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 35.28 | 51.70 |
| Support Level | $0.11 | $0.56 |
| Resistance Level | $1.20 | $7.15 |
| Average True Range (ATR) | 0.11 | 1.29 |
| MACD | -0.02 | -0.37 |
| Stochastic Oscillator | 2.40 | 0.86 |
Price Performance
Historical ComparisonAbout NUWE Nuwellis Inc.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.